Search results
Results From The WOW.Com Content Network
On Friday, Nasdaq Inc’s (NASDAQ:NDAQ) annual reconstitution of the Nasdaq-100 Index will become effective before the market opens on December 23. Illumina, Inc. (NASDAQ:ILMN) was removed from ...
(Reuters) -Illumina's board has approved a spinoff of Grail, the gene sequencing machine maker said on Monday, as the deal to take the company back into its fold three years ago faced immense ...
(Reuters) - Gene sequencing machine maker Illumina on Tuesday forecast 2024 sales from its core segment to decline, a sign that subdued demand for its instruments used in genetic tests could ...
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California.Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function.
Illumina expects full-year adjusted profit per share to be between $0.75 and $0.90, compared with its prior forecast of $1.25 to $1.50. The outlook reflects a tax expense impact of about $75 million.
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California. It was previously a subsidiary of Illumina started as a startup seeking to develop an early cancer screening test for people who do not have symptoms. [3] Grail was spun-out from Illumina on June 24, 2024.
Anthony William Czarnik (born 1957) is an American chemist and inventor.He is best known for pioneering studies in the field of fluorescent chemosensors [6] [7] [2] [8] and co-founding Illumina, Inc., a biotechnology company in San Diego.
Illumina sees full-year adjusted profit per share to be between $0.60 and $0.70, versus its prior forecast range of $0.75 to $0.90. ... In Other News. Entertainment. Entertainment. People